Skip to content
healthcare.dev

Mucus Relief Cough and Congestion DM

NDC 17714-150, Guaifenesin and Dextromethorphan HBr, tablet, from Advance Pharmaceutical Inc..

Product NDC
17714-150
Status
Listed
Labeler
Advance Pharmaceutical Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH FINAL
Application
part341
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17714-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROMETHORPHAN HYDROBROMIDE20 mg/1
  • GUAIFENESIN400 mg/1

Pharmacologic classes

Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
17714-150-601771401506060 TABLET in 1 BOTTLE (17714-150-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17714-150 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17714-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17714-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.